(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott released the following statement on new National Health Expenditure (NHE) data from the Centers for Medicare & Medicaid Services: “The latest National Healthcare Expenditure data from CMS offers
Unlocking an Affordable Future: Key #2 Support and Equip Clinicians SUPPORT AND EQUIP CLINICIANS WITH TOOLS AND DATA TO SERVE PATIENTS OPTIMALLY Physicians, pharmacists, and other health care providers are valued employees within pharmacy benefit companies and esteemed healthcare partners outside
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA), today, is announcing a new ad campaign, “Drug Manufacturers are Pointing Fingers…Again.” With Congress poised to permanently repeal the rebate rule and prevent significant increases in both Medicare beneficiary premiums and Medicare
(Washington, D.C.) — As part of its OnYourRxSide campaign, the Pharmaceutical Care Management Association (PCMA) today released a new video — “What is a PBM?” — detailing the role pharmacy benefit managers (PBMs) play in the prescription drug supply chain
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) today released a new report, “Drug Manufacturer Strategies for Keeping Drug Costs High,” on pharmaceutical industry pricing tactics that increase prescription drug costs for patients. The report, conducted by the research firm Visante,
(Washington, D.C.) — As the Administration considers modifying price concessions for prescription drugs in Medicare and federal programs, the Pharmaceutical Care Management Association (PCMA) is releasing new data, “Reconsidering Drug Prices, Rebates, and PBMs,” showing drug manufacturers alone set prices –
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement on passage of prescription drug legislation in New Jersey. “PCMA applauds the New Jersey Assembly for passing S2690 / A3993 / A 2214, legislation that will help ensure New
The vast majority of employers and public health programs voluntarily work with pharmacy benefit companies to manage pharmacy benefits. So, what happens when a health plan doesn’t use a pharmacy benefit company? A recent Department of Labor (DOL) Office of the
In case you missed it, the National Institute for Public Employee Health Care Policy recently released a report, “How Public Sector Health Care Purchasers Are Addressing Rising Drug Costs.” According to the report, “Through pooled purchasing organizations, employers in the
(Washington, D.C.) — Senior registered voters enrolled in Medicare Part D will be less likely to support the reelection of their members of Congress and presidential candidates if those elected officials back proposals eliminating prescription drug negotiations and price concessions
©2024 PCMA. All Rights Reserved.
